Studies on the role of the extracellular cysteines and oligomeric structures of the P2Y12 receptor when interacting with antagonists

被引：34

作者：

Ding, Z. ^{[1
,2
]}

Bynagari, Y. S. ^{[1
]}

Mada, S. R. ^{[1
]}

Jakubowski, J. A. ^{[3
]}

Kunapuli, S. P. ^{[1
,2
,4
]}

机构：

[1] Temple Univ, Dept Physiol, Sch Med, Philadelphia, PA 19140 USA

[2] Temple Univ, Dept Pharmacol, Sch Med, Philadelphia, PA 19140 USA

[3] Temple Univ, Sol Sherry Thrombosis Res Ctr, Sch Med, Philadelphia, PA 19140 USA

[4] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA

来源：

JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2009年 / 7卷 / 01期

关键词：

PLATELET ADP RECEPTOR; ACTIVE METABOLITE; IDENTIFICATION;

D O I：

10.1111/j.1538-7836.2008.03202.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：232 / 234

页数：3

共 12 条

[1] Inactivation of the human P2Y12 receptor by thiol reagents requires interaction with both extracellular cysteine residues, Cys17 and Cys270 [J].

Ding, ZR ;

Kim, S ;

Dorsam, RT ;

Jin, JG ;

Kunapuli, SP .

BLOOD, 2003, 101 (10) :3908-3914

[2] Central role of the P2Y12 receptor in platelet activation [J].

Dorsam, RT ;

Kunapuli, SP .

JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (03) :340-345

[3] Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs [J].

Foster, CJ ;

Prosser, DM ;

Agans, JM ;

Zhai, Y ;

Smith, MD ;

Lachowicz, JE ;

Zhang, FL ;

Gustafson, E ;

Monsma, FJ ;

Wiekowski, MT ;

Abbondanzo, SJ ;

Cook, DN ;

Bayne, ML ;

Lira, SA ;

Chintala, MS .

JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (12) :1591-1598

[4] Identification of the platelet ADP receptor targeted by antithrombotic drugs [J].

Hollopeter, G ;

Jantzen, HM ;

Vincent, D ;

Li, G ;

England, L ;

Ramakrishnan, V ;

Yang, RB ;

Nurden, P ;

Nurden, A ;

Julius, D ;

Conley, PB .

NATURE, 2001, 409 (6817) :202-207

[5] Prasugrel: A novel thienopyridine antiplatelet agent. A review of preclinical and clinical studies and the mechanistic basis for its distinct antiplatelet profile [J].

Jakubowski, Joseph A. ;

Winters, Kenneth J. ;

Naganuma, Hideo ;

Wallentin, Lars .

CARDIOVASCULAR DRUG REVIEWS, 2007, 25 (04) :357-374

[6] Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation [J].

Jin, JG ;

Kunapuli, SP .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (14) :8070-8074

[7] Identification and biological activity of the active metabolite of clopidogrel [J].

Savi, P ;

Pereillo, JM ;

Uzabiaga, MF ;

Combalbert, J ;

Picard, C ;

Maffrand, JP ;

Pascal, M ;

Herbert, JM .

THROMBOSIS AND HAEMOSTASIS, 2000, 84 (05) :891-896

[8] P2Y12, a new platelet ADP receptor, target of clopidogrel [J].

Savi, P ;

Labouret, C ;

Delesque, N ;

Guette, F ;

Lupker, J ;

Herbert, JM .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 283 (02) :379-383

[9] The active metabolite of Clopidogrel disrupts P2Y12 receptor oligomers and partitions them out of lipid rafts [J].

Savi, Pierre ;

Zachayus, Jean-Luc ;

Delesque-Touchard, Nathalie ;

Labouret, Catherine ;

Herve, Caroline ;

Uzabiaga, Marie-Francoise ;

Pereillo, Jean-Marie ;

Culouscou, Jean-Michel ;

Bono, Francoise ;

Ferrara, Pascual ;

Herbert, Jean-Marc .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (29) :11069-11074

[10] Antiplatelet action of R-99224, an active metabolite of a novel thienopyridine-type Gi-linked P2T antagonist, CS-747 [J].

Sugidachi, A ;

Asai, F ;

Yoneda, K ;

Iwamura, R ;

Ogawa, T ;

Otsuguro, K ;

Koike, H .

BRITISH JOURNAL OF PHARMACOLOGY, 2001, 132 (01) :47-54

← 1 2 →